Cholera toxin and related enterotoxins: A cell biological and immunological perspective

Journal of Natural Toxins

Volumn 9, Issue 3, 2000, Pages 281-296

  De Haan, L ^a   Hirst, T R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CHOLERA TOXIN; ENTEROTOXIN; VACCINE;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BINDING SITE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMISTRY; ESCHERICHIA COLI; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; MACROPHAGE; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIBRIO CHOLERAE;

ANTIBODY FORMATION; ANTIGENS, BACTERIAL; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BINDING SITES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHOLERA TOXIN; ENTEROTOXINS; ESCHERICHIA COLI; HUMANS; IMMUNITY, CELLULAR; INTESTINAL MUCOSA; MACROPHAGES; VACCINES; VIBRIO CHOLERAE;

EID: 0033850599     PISSN: 10588108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (125)

1. Cholera toxin inhibits resting human T cell activation via a cAMP independent pathway
2. Dendritic cells and the control of immunity
3. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes
4. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina
5. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens
6. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression
7. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro
8. AB(5) ADP-ribosylating toxins. Comparative anatomy and physiology
9. Mechanism of cholera toxin action: Covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system
10. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: Disproportionate cholera toxin enhancement of the IgA B cell response
11. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)
12. Role of a potential endoplasmic reticulum retention sequence (RDEL) and the Golgi complex in the cytotonic activity of Escherichia coli heat-labile enterotoxin
13. Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant
14. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated antigens
15. Identification of an immunodominant T cell epitope on cholera toxin
16. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression
17. Gangliosides and membrane receptors for cholera toxin
18. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans
19. Amino acid sequence homology between Cholera toxin and Escherichia coli heat-labile toxin
20. Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding
21. Mutational analysis of the role of ADP-ribosylation activity and G(M1)-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin
22. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin
23. Role of G(M1)-binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit
24. Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin
25. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant
26. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity
27. Identification of errors among database sequence entries and comparison of correct amino acid sequences for the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae
28. Inhibition of heat-labile cholera and Escherichia coli enterotoxins by Brefeldin A
29. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants
30. Mucosal immunogenicity of genetically detoxified derivatives of heat-labile toxin from Escherichia coli
31. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
32. Cholera toxin as a mucosal adjuvant: Effects of H-2 major histocompatibility complex and 1ps genes
33. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen
34. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin
35. Activation of cholera toxin-specific T cells in vitro
36. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit
37. Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins
38. Cyclic AMP independent effects of cholera toxin on B cell activation. II. Binding of G(M1) induces B cell activation
39. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins L Th-I, LT-IIa, and LT-IIb
40. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
41. Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers
42. Lipid phase separations induced by the association of cholera toxin to phospholipid membranes containing ganglioside G(M1)
43. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin
44. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
45. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells
46. Cholera toxin and Escherichia coli heat-labile enterotoxin
47. Cellular location of heat-labile enterotoxin in Escherichia coli
48. Mechanism of toxin secretion by Vibrio colerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli
49. Kinetics of synthesis, processing and membrane transport of heat-labile enterotoxin, a periplasmic protein in Escherichia coli
50. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin
51. Cholera toxin and cholera toxin B subunit as oral-mucosal adjuvant and antigen vector systems
52. Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation
53. Cholera toxin adjuvant greatly promotes antigen priming of T cells
54. CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin
55. Optimizing oral vaccines: Induction of systemic and mucosal B cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant
56. Activation of rat liver adenylate cyclase by cholera toxin requires toxin internalization and processing in endosomes
57. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells?
58. Selective effects of cholera toxin on the activation of mouse B cells by different polyclonal activators
59. Targeting of cholera toxin and Escherichia coli heat-labile toxin in polarized epithelia: Role of COOH-terminal KDEL
60. Proteolytic activation of cholera toxin and Escherichia coli labile toxin by entry into host epithelial cells. Signal transduction by a protease-resistant toxin variant
61. Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: Role of vesicular traffic
62. Membrane traffic and the cellular uptake of cholera toxin
63. Transcytosis of cholera toxin subunits across model human intestinal epithelia
64. Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin
65. Identification of the site of uptake of the E. coli heat-labile enterotoxin, LTB
66. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens
67. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity
68. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb
69. Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit
70. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages
71. Crystal structure of cholera toxin B-pentamer bound to receptor G(M1) pentasaccharide
72. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
73. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins
74. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor
75. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation
76. Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches
77. Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia coli heat-labile enterotoxin (rEtxB) and cholera toxin (rCtxB)
78. Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: Receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1
79. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets
80. Cross-linking of cell surface ganglioside G(M1) induces the selective apoptosis of mature CD8+ T lymphocytes
81. Synthesis and secretion of the plasmid-coded heat-labile enterotoxin of Escherichia coli in Vibrio cholerae
82. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4(+) Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses
83. Protein-disulfide isomerase mediated reduction of the A subunit of cholera toxin in a human intestinal cell line
84. Brefeldin A blocks the response of cultured cells to cholera toxin
85. The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide
86. Antigenic specificity of neutralizing antibody to cholera toxin
87. Cloning of genes that encode a new heat-labile enterotoxin of Escherichia coli
88. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit
89. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo
90. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: Selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue
91. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory
92. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
93. Production and characterization of monoclonal antibodies to cholera toxin
94. Structural basis for the differential toxicity of cholera toxin and Escherichia coli heat-labile enterotoxin. Construction of hybrid toxins identifies the A2-domain as the determinant of differential toxicity
95. Enteric bacterial toxins: Mechanisms of action and linkage to intestinal secretion
96. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
97. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin
98. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli
99. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins
100. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse
101. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin
102. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit
103. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine
104. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin
105. Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine
106. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine
107. Comparison of the glycolipid-binding specificities of cholera toxin and porcine Escherichia coli heat-labile enterotoxin: Identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine
108. Intranasal immunization with liposomes induces strong mucosal immune responses in mice
109. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunisation with cholera toxin adjuvant
110. Impaired mucosal immune responses in interleukin 4-targeted mice
111. Crystal structure of a new heat-labile enterotoxin, LT-IIb
112. Mucosal immunoadjuvant activity of the recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza surface antigen
113. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic
114. Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin
115. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant
116. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia
117. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin
118. Induction of mucosal immunity by intranasal application of a Streptococcal surface protein antigen with the cholera toxin B subunit
119. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant
120. Helper T cell subsets for immunoglobulin A responses: Oral immunisation with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues
121. Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant
122. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
123. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity
124. Evolution and structure of two ADP-ribosylation enterotoxins, Escherichia coli heat-labile enterotoxin and cholera toxin
125. The three-dimensional crystal structure of cholera toxin